CBD Vegan Gummies Reach Amazon, CBD Life Sciences Confirms


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


CBD Life Sciences (OTC:CBDL) via its wholly owned subsidiary, LBC Bioscience Inc. is launching its top selling 300MG strawberry lemonade vegan gummies on Amazon (NASDAQ:AMZN) by the end of this week.

President & CEO Lisa Nelson stated: "We want to give the customers more of an option when it comes to taking CBD and this is the perfect step in the right direction to provide vegans with the most top shelf gummies on the market! Our vegan gummies do not contain any toxins that ensure long shelf life. They are also eco-friendly and use naturally available materials to grow the hemp plant organically for making the CBD gummies."

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Benefits of using these gummies may help with suppressing inflammation due to it being rich in antioxidants along with pain relief and promoting a healthy sleep cycle.

About LBC Bioscience Inc.

 

LBC Bioscience has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD drops, gumballs, honey sticks, pain relief creams, anxiety & sleep supplements, edibles, coffee, skincare line, pet line, tablets and more.

Photo: Courtesy of Christian Wiediger on Unsplash


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: CannabisNewsPenny StocksMarketsCBD GummiesLBC BioscienceLisa Nelson